Clinical Trial Update: Study to Learn More About the Safety and Effectiveness of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Indian People With Narrowing of the Arteries of the Heart (CAD) and/or With Reduced Blood Flow in the Arteries of the Legs and Arms With Symptoms (Symptomatic PAD)

View source ↗

Summary

A completed clinical trial evaluated the safety and effectiveness of rivaroxaban (Xarelto) taken with aspirin in Indian patients with coronary artery disease an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Peripheral Artery Disease

Drugs mentioned

• Aspirin (Aspirin)
• Xarelto (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Prevention of Atherothrombotic Events, Coronary Artery Disease (CAD) | Status: COMPLETED